Titre : Mouvements de l'eau

Mouvements de l'eau : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mouvements de l'eau : Questions médicales les plus fréquentes", "headline": "Mouvements de l'eau : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mouvements de l'eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mouvements de l'eau" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Environnement", "url": "https://questionsmedicales.fr/mesh/D004777", "about": { "@type": "MedicalCondition", "name": "Environnement", "code": { "@type": "MedicalCode", "code": "D004777", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.230" } } }, "about": { "@type": "MedicalCondition", "name": "Mouvements de l'eau", "alternateName": "Water Movements", "code": { "@type": "MedicalCode", "code": "D014872", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ryan S Wagner", "url": "https://questionsmedicales.fr/author/Ryan%20S%20Wagner", "affiliation": { "@type": "Organization", "name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States." } }, { "@type": "Person", "name": "Katelyn M McKindles", "url": "https://questionsmedicales.fr/author/Katelyn%20M%20McKindles", "affiliation": { "@type": "Organization", "name": "Great Lakes Center for Fresh Waters and Human Health, Bowling Green State University, Bowling Green, OH, United States." } }, { "@type": "Person", "name": "George S Bullerjahn", "url": "https://questionsmedicales.fr/author/George%20S%20Bullerjahn", "affiliation": { "@type": "Organization", "name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States." } }, { "@type": "Person", "name": "Miguel A Gonzalez", "url": "https://questionsmedicales.fr/author/Miguel%20A%20Gonzalez", "affiliation": { "@type": "Organization", "name": "Universidad Rey Juan Carlos, ESCET, Mostoles, 28933 Madrid, Spain." } }, { "@type": "Person", "name": "Alberto Zaragoza", "url": "https://questionsmedicales.fr/author/Alberto%20Zaragoza", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Utah, Salt Lake City, Utah 84112-0850, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Therapy decisions after diagnosis of prostate cancer in men with negative prostate MRI.", "datePublished": "2022-09-08", "url": "https://questionsmedicales.fr/article/36073730", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/pros.24435" } }, { "@type": "ScholarlyArticle", "name": "Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.", "datePublished": "2023-09-13", "url": "https://questionsmedicales.fr/article/37620288", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/bju.16167" } }, { "@type": "ScholarlyArticle", "name": "Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer.", "datePublished": "2022-09-15", "url": "https://questionsmedicales.fr/article/36056577", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ijc.34274" } }, { "@type": "ScholarlyArticle", "name": "Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36063405", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/pros.24433" } }, { "@type": "ScholarlyArticle", "name": "Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.", "datePublished": "2024-06-03", "url": "https://questionsmedicales.fr/article/38833252", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.14582" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Environnement", "item": "https://questionsmedicales.fr/mesh/D004777" }, { "@type": "ListItem", "position": 4, "name": "Mouvements de l'eau", "item": "https://questionsmedicales.fr/mesh/D014872" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mouvements de l'eau - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mouvements de l'eau", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mouvements de l'eau", "description": "Comment diagnostiquer une déshydratation ?\nQuels tests pour évaluer l'équilibre hydrique ?\nQuels signes indiquent une surcharge hydrique ?\nComment détecter un déséquilibre électrolytique ?\nQuels symptômes nécessitent un diagnostic urgent ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mouvements de l'eau", "description": "Quels sont les symptômes de la déshydratation ?\nComment reconnaître une surcharge hydrique ?\nQuels signes indiquent un déséquilibre hydrique ?\nQuels symptômes sont liés à l'hyperhydratation ?\nQuels symptômes d'un choc hypovolémique ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mouvements de l'eau", "description": "Comment prévenir la déshydratation ?\nQuelles mesures pour éviter la surcharge hydrique ?\nComment maintenir un bon équilibre hydrique ?\nQuelles précautions pour les athlètes ?\nComment prévenir les déséquilibres électrolytiques ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mouvements de l'eau", "description": "Comment traiter la déshydratation légère ?\nQuel traitement pour la surcharge hydrique ?\nComment gérer un déséquilibre électrolytique ?\nQuel est le traitement de l'hyperhydratation ?\nComment traiter un choc hypovolémique ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mouvements de l'eau", "description": "Quelles complications de la déshydratation sévère ?\nQuels risques d'une surcharge hydrique prolongée ?\nQuelles complications d'un déséquilibre électrolytique ?\nQuels dangers de l'hyperhydratation ?\nQuelles complications du choc hypovolémique ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mouvements de l'eau", "description": "Quels facteurs augmentent le risque de déshydratation ?\nQui est à risque de surcharge hydrique ?\nQuels médicaments augmentent le risque d'un déséquilibre électrolytique ?\nQuels comportements augmentent le risque d'hyperhydratation ?\nQuels facteurs de risque pour le choc hypovolémique ?", "url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=Prostatic+Neoplasms&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déshydratation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par l'évaluation des symptômes cliniques et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'équilibre hydrique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins, urinaires et des mesures de poids peuvent être utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une surcharge hydrique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent œdème, hypertension et dyspnée." } }, { "@type": "Question", "name": "Comment détecter un déséquilibre électrolytique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des analyses sanguines mesurant les niveaux de sodium et potassium." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un diagnostic urgent ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Confusion, convulsions ou perte de conscience doivent être évalués rapidement." } }, { "@type": "Question", "name": "Quels sont les symptômes de la déshydratation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Soif intense, sécheresse de la peau, fatigue et urine foncée." } }, { "@type": "Question", "name": "Comment reconnaître une surcharge hydrique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent gonflement des membres, essoufflement et prise de poids rapide." } }, { "@type": "Question", "name": "Quels signes indiquent un déséquilibre hydrique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, crampes musculaires et troubles de la concentration." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'hyperhydratation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Nausées, maux de tête et confusion mentale peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes d'un choc hypovolémique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pulsations rapides, peau froide et confusion mentale sont des indicateurs." } }, { "@type": "Question", "name": "Comment prévenir la déshydratation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Boire régulièrement de l'eau, surtout par temps chaud ou lors d'exercices." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la surcharge hydrique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Limiter l'apport en liquides et surveiller les signes d'œdème." } }, { "@type": "Question", "name": "Comment maintenir un bon équilibre hydrique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Consommer des aliments riches en eau et surveiller l'apport en électrolytes." } }, { "@type": "Question", "name": "Quelles précautions pour les athlètes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "S'hydrater avant, pendant et après l'exercice pour éviter la déshydratation." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres électrolytiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Avoir une alimentation équilibrée et surveiller les niveaux lors de maladies." } }, { "@type": "Question", "name": "Comment traiter la déshydratation légère ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation orale avec des solutions électrolytiques est recommandée." } }, { "@type": "Question", "name": "Quel traitement pour la surcharge hydrique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Restriction hydrique et diurétiques peuvent être prescrits." } }, { "@type": "Question", "name": "Comment gérer un déséquilibre électrolytique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments ou des modifications alimentaires peuvent être nécessaires." } }, { "@type": "Question", "name": "Quel est le traitement de l'hyperhydratation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Réduction de l'apport hydrique et administration de diurétiques." } }, { "@type": "Question", "name": "Comment traiter un choc hypovolémique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Administration rapide de fluides intraveineux et traitement de la cause sous-jacente." } }, { "@type": "Question", "name": "Quelles complications de la déshydratation sévère ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner des lésions rénales, des convulsions et un choc hypovolémique." } }, { "@type": "Question", "name": "Quels risques d'une surcharge hydrique prolongée ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Peut causer un œdème pulmonaire et des troubles cardiaques." } }, { "@type": "Question", "name": "Quelles complications d'un déséquilibre électrolytique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner des arythmies cardiaques et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels dangers de l'hyperhydratation ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Peut provoquer un œdème cérébral et des troubles de la conscience." } }, { "@type": "Question", "name": "Quelles complications du choc hypovolémique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner une défaillance multi-organique et un décès si non traité." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de déshydratation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Âge avancé, maladies chroniques et climat chaud sont des facteurs de risque." } }, { "@type": "Question", "name": "Qui est à risque de surcharge hydrique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes avec insuffisance cardiaque ou rénale sont particulièrement à risque." } }, { "@type": "Question", "name": "Quels médicaments augmentent le risque d'un déséquilibre électrolytique ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les diurétiques et certains laxatifs peuvent provoquer des déséquilibres." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque d'hyperhydratation ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive de liquides sans équilibre électrolytique peut être risquée." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le choc hypovolémique ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Traumatismes, hémorragies et déshydratation sévère augmentent le risque." } } ] } ] }

Sources (10000 au total)

Therapy decisions after diagnosis of prostate cancer in men with negative prostate MRI.

To investigate the clinical implications of magnetic resonance imaging (MRI) negative prostate cancer (PCa) in a cohort of men undergoing transperineal prostate biopsy.... We included all men without prior diagnosis of PCa undergoing transperineal template saturation ± fusion-guided targeted biopsy of the prostate between November 2014 and March 2018. Before biopsy, all... From 515 patients undergoing prostate biopsy, 171 (33.2%) patients had a negative and 344 (66.8%) a positive MRI. Pathology review stratified for MRI negative and positive cases revealed nsPCa in 27 (... Only few men with MRI negative PCa need active cancer treatment at the time of diagnosis, while the majority opts for AS. Omitting prostate biopsies and performing a follow-up MRI may be a safe altern...

Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.

To assess whether a diagnostic pathway in which prostate-specific membrane antigen (PSMA) positron-emission tomography (PET)/computed tomography (CT) is used as a single imaging modality is feasible t... A total of 60 men with a prostate-specific antigen (PSA) level of 20-50 ng/mL underwent... Lesions suspicious for PCa in the prostate gland were observed on all PSMA-PET/CTs. A total of 27/60 men (45%) already had metastatic disease on staging... Using the PSMA-driven single imaging modality pathway in biopsy-naïve men at high-risk of PCa, a substantial number of diagnostic MRI scans could be avoided while at the same time obtaining adequate t...

Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates.

The surgical treatment of men with lower urinary tract symptoms (LUTS) and significantly enlarged symptomatic prostates on active surveillance (AS) for low-risk prostate cancer (PCa) is not well defin... Men on AS who underwent HoLEP between 2013 and 2019 were identified. Data regarding preoperative cancer workup, prostate-specific antigen (PSA), perioperative outcomes, and voiding parameters were ana... Twenty men met the inclusion criteria. Preoperative mean max flow 7.9 ml/s, median postvoid residual 101 cc, and mean transrectal ultrasound prostate size 99 cc. Patients had a median adjusted preoper... Men on AS for low-risk PCa can safely undergo HoLEP with significantly improved voiding parameters. Postoperative monitoring with PSA, mpMRI, and PBx can detect disease progression requiring definitiv...

Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.

Prostate-specific antigen (PSA) screening for prostate cancer is controversial but may be associated with benefit for certain high-risk groups.... To evaluate associations of county-level PSA screening prevalence with prostate cancer outcomes, as well as variation by sociodemographic and clinical factors.... This cohort study used data from cancer registries based in 8 US states on Hispanic, non-Hispanic Black, and non-Hispanic White men aged 40 to 99 years who received a diagnosis of prostate cancer betw... County-level PSA screening prevalence was estimated using the Behavior Risk Factor Surveillance System survey data from 2004, 2006, 2008, 2010, and 2012 and weighted by population characteristics.... Multivariable logistic, Cox proportional hazards regression, and competing risks models were fit to estimate adjusted odds ratios (AOR) and adjusted hazard ratios (AHR) for associations of county-leve... Of 814 987 men with prostate cancer, the mean (SD) age was 67.3 (9.8) years, 7.8% were Hispanic, 12.2% were non-Hispanic Black, and 80.0% were non-Hispanic White; 17.0% had advanced disease. There wer... This population-based cohort study of men with prostate cancer suggests that higher county-level prevalence of PSA screening was associated with lower odds of advanced disease, all-cause mortality, an...

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen.

The incidence rate of prostate cancer (PCa) has continued to rise in Korea. This study aimed to construct and evaluate a 5-year PCa risk prediction model using a cohort with PSA < 10 ng/mL by incorpor... The PCa risk prediction model including PSA levels and individual risk factors was constructed using a cohort of 69,319 participants from the Kangbuk Samsung Health Study. 201 registered PCa incidence... The risk prediction model included age, smoking status, alcohol consumption, family history of PCa, past medical history of dyslipidemia, cholesterol levels, and PSA level. Especially, an elevated PSA... Our risk prediction model was effective in predicting PCa in a population according to PSA levels. When PSA levels are inconclusive, an assessment of both PSA and specific individual risk factors (e.g...

Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.

Local recurrences after previous radiotherapy (RT) are increasingly being identified in biochemically recurrent prostate cancer. Salvage prostate brachytherapy (BT) is an effective and well tolerated ... International experts in salvage prostate BT were invited (n = 34) to participate. A three-round modified Delphi technique was utilized, with questions focused on patient- and cancer-specific criteria... Thirty international experts agreed to participate. Consensus was achieved for 56% (18/32) of statements. Consensus was achieved in several areas of patient selection: 1) A minimum of 2-3 years from i... Areas of consensus within our Delphi study may serve as practical advice for salvage prostate BT. Future research in salvage BT should address areas of controversy identified in our study....

Bidirectional influence between benign prostatic hyperplasia, prostate cancer, and prostatitis and mental disorders: two-sample and multivariate mendelian randomization analyses.

We aimed to use Mendelian randomization (MR) to determine the causality between fifteen major mental disorders (MDs) and benign prostatic hyperplasia (BPH), prostate cancer (PCa), and prostatitis.... The main MR analysis was performed using the inverse variance-weighted (IVW) method.... The study found that insomnia (odds ratio [OR], 1.6190;... Our findings provide clinicians with a basis for developing programs to prevent or treat MDs and prostatic diseases....

A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing.

To evaluate the feasibility of AI-assisted reading of prostate magnetic resonance imaging (MRI) in Organized Prostate cancer Testing (OPT).... Retrospective cohort study including 57 men with elevated prostate-specific antigen (PSA) levels ≥3 µg/L that performed bi-parametric MRI in OPT. The results of a CE-marked deep learning (DL) algorith... The number of positive MRIs was 13 (23%), 8 (14%), and 29 (51%) for the local radiologists, expert consensus, and DL, respectively. Kappa scores were moderate for local radiologists versus expert cons... The Dl-algorithm showed low agreement with both local and expert radiologists. Training and validation of DL-algorithms in specific screening cohorts is essential before introduction in organized test...